Biochemical basis and therapeutic potential of mitochondrial uncoupling in cardiometabolic syndrome
Biochemical Journal · 04.12.2024 · 481 (23) · 1831-1854
DOI: 10.1042/bcj20240005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Journal, online erschienen am 04.12.2024. Verfasst von Bernardo Gindri Dos Santos und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (Cardiology), The Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, U.S.A. Hauptthemen laut MEDLINE: Metabolic Syndrome, Mitochondria, Uncoupling Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 247 Literaturangaben. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Mild uncoupling of oxidative phosphorylation is an intrinsic property of all mitochondria, allowing for adjustments in cellular energy metabolism to maintain metabolic homeostasis. Small molecule uncouplers have been extensively studied for their potential to increase metabolic rate, and recent research has focused on developing safe and effective mitochondrial uncoupling agents for the treatment of obesity and cardiometabolic syndrome (CMS). Here, we provide a brief overview of CMS and cover the recent mechanisms by which chemical uncouplers regulate CMS-associated risk-factors and comorbidities, including dyslipidemia, insulin resistance, steatotic liver disease, type 2 diabetes, and atherosclerosis. Additionally, we review the current landscape of uncoupling agents, focusing on repurposed FDA-approved drugs and compounds in advanced preclinical or early-stage clinical development. Lastly, we discuss recent molecular insights by which chemical uncouplers enhance cellular energy expenditure, highlighting their potential as a new addition to the current CMS drug landscape, and outline several limitations that need to be addressed before these agents can successfully be introduced into clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine (Cardiology), The Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, U.S.A.
- Department of Medicine (Endocrinology), The Diabetes, Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY, U.S.A.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Dos Santos, B. G., Brisnovali, N. F., & Goedeke, L. (2024). Biochemical basis and therapeutic potential of mitochondrial uncoupling in cardiometabolic syndrome. Biochemical Journal, 481(23), 1831-1854. https://doi.org/10.1042/bcj20240005
Vancouver
Dos Santos BG, Brisnovali NF, Goedeke L. Biochemical basis and therapeutic potential of mitochondrial uncoupling in cardiometabolic syndrome. Biochemical Journal. 2024;481(23):1831-1854. doi:10.1042/bcj20240005
BibTeX
@article{DosSantos2024,
author = {Dos Santos, Bernardo Gindri and Brisnovali, Niki F and Goedeke, Leigh},
title = {Biochemical basis and therapeutic potential of mitochondrial uncoupling in cardiometabolic syndrome},
journal = {Biochemical Journal},
year = {2024},
volume = {481},
number = {23},
pages = {1831--1854},
doi = {10.1042/bcj20240005}
}
EUVIMED